First use of cenerimod, a selective S1P1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study

Overview of attention for article published in Lupus Science & Medicine, November 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#22 of 477)
High Attention Score compared to outputs of the same age (95th percentile)

Mentioned by

news: 5 news outlets
twitter: 23 X users

patent: 1 patent
facebook: 1 Facebook page

Citations

dimensions_citation: 41 Dimensions

Readers on

mendeley: 31 Mendeley

Summary News X Patents Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Lupus Science & Medicine, 11 Nov 2019

Phase 2 study on the use of cenerimod (selective S1P1 receptor modulator) for SLE presented by @Idorsia at #ACR19. Read the…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.